Not recruiting
Systemic scleroderma+3
Not recruitingA Study of Cizutamig for Patients with Severe Autoimmune Inflammatory Diseases That Did Not Respond to Previous Treatments
InvestigationalNo placebo
A Study of Cizutamig for Patients with Severe Autoimmune Inflammatory Diseases That Did Not Respond to Previous Treatments
InvestigationalNo placebo
- Disease:Systemic sclerodermaRheumatoid arthritis+2
- Substances:Cizutamig
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Cizutamig
